Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice (Q28547778): Difference between revisions
Jump to navigation
Jump to search
Set a claim value: cites work (P2860): Formulation and performance evaluation of betahistine dihydrochloride microspheres as sustained release systems (Q41690419), разрешение перенаправления / resolving redirect (Q43823337) → Formulation and performance evaluation of betahistine dihydrochloride microspheres as sustained release systems (Q41690419) (подробности / details) |
Updated Item: Adding statements: cites work (P2860) |
||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Formulation and performance evaluation of betahistine dihydrochloride microspheres as sustained release systems / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work: Formulation and performance evaluation of betahistine dihydrochloride microspheres as sustained release systems / reference | |||||||||||||||
stated in: PubMed reference URL: https://pubmed.ncbi.nlm.nih.gov/26352932 retrieved: 12 December 2020
based on heuristic: inferred from PubMed ID database lookup |
Revision as of 02:01, 22 July 2021
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice |
scientific article |
Statements
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice (English)
0 references
2015
0 references
9
0 references
9
0 references
e0003950
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference